Close Menu

NEW YORK(GenomeWeb) – Where mass spec-based microbiology is concerned, MALDI has largely led the way, with commercial platforms from Bruker and BioMérieux in recent years receiving regulatory approvals and winning clinical customers around the world.

If the Mass Spectrometry Applications to the Clinical Laboratory annual meeting held last month inSan Diegois any indication, though, the clinical microbiology field is looking beyond MALDI for the next generation of mass spec-based tools.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.